Rani Therapeutics

RANINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$98.115 M

$0.79 +1.40%

Close of 7 Aug 2026

Revenue

$1.63M

#3459 by revenue

Earnings

-$29.7M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#304Polaryx TherapeuticsPLYX$112.7M
#305RafaelRFL$106.6M
#306Rani TherapeuticsRANI$98.1M
#307Oncolytics BiotechONCY$95.8M
#308Aldeyra TherapeuticsALDX$93.5M

Where these numbers come from

Share counts and financials for Rani Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.